Telcare glucose monitor receives FDA approval

Telcare Inc. just announced it received clearance from the U.S. Food and Drug Administration for its mobile blood glucose monitor and the accompanying database. The blood glucose monitor's claim to fame amid the myriad of mobile BGMs: It automatically sends the information to whatever database the patient or provider wants, including to personal health records like Microsoft's HealthVault. Alerts on high or low readings also can be automatically sent from the monitor to family, caregivers and friends, if they are part of the patient's support network, according to healthcare blogger The Medical Quack. Announcement

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.